Intracoronary administration of autologous bone marrow-derived progenitor cells in a critically ill two-yr-old child with dilated cardiomyopathy

Pediatric Transplantation

Volumn 13, Issue 5, 2009, Pages 620-623

  Rupp, Stefan ^a   Bauer, Jürgen ^a   Tonn, Torsten ^b   Schächinger, Volker ^c   Dimmeler, Stefanie ^c   Zeiher, Andreas M ^c   Schranz, Dietmar ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b Institute of Transfusion Medicine and Immunohaematology   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

Dilated cardiomyopathy; Heart failure; Heart transplantation; Stem cell therapy

Indexed keywords

BISOPROLOL; DIGITALIS; FUROSEMIDE; IMMUNOGLOBULIN; LISINOPRIL; MILRINONE; SPIRONOLACTONE;

ANGIOCARDIOGRAPHY; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CARDIOMYOPATHY; CASE REPORT; CHILD; CONGESTIVE CARDIOMYOPATHY; CRITICALLY ILL PATIENT; DISEASE COURSE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INTRACORONARY INFUSION; MALE; MYOCARDITIS; PATIENT SAFETY; STEM CELL TRANSPLANTATION;

ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, CD45; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CARDIOMYOPATHY, DILATED; CHILD, PRESCHOOL; CORONARY VESSELS; DISEASE PROGRESSION; GLYCOPROTEINS; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; MALE; PEPTIDES; STEM CELLS; TREATMENT OUTCOME;

EID: 67651204283     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.01024.x     Document Type: Article

References (21)

1. Canter CE, Shaddy RE, Bernstein D, et al. Indications for heart transplantation in pediatric heart disease: A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007 : 115 : 658 676.
2. Arola A, Tuominen J, Ruuskanen O, Jokinen E. Idiopathic dilated cardiomyopathy in children: Prognostic indicators and outcome. Pediatrics 1998 : 101 : 369 376. (Pubitemid 28136408)
3. Nugent AW, Daubeney PE, Chondros P, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 2003 : 348 : 1639 1646.
4. Alvarez J, Wilkinson JD, Lipshultz SE for the Pediatric Cardiomyopathy Registry Study Group. Outcome predictors for pediatric dilated cardiomyopathy: A systematic review. Prog Pediatr Cardiol 2007 : 25 32.
5. Assmus B, Honold J, Schachinger V, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006 : 355 : 1222 1232. (Pubitemid 44427446)
6. Schachinger V, Erbs S, Elsasser A, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006 : 355 : 1210 1221. (Pubitemid 44427445)
7. Assmus B, Schachinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002 : 106 : 3009 3017.
8. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001 : 410 : 701 705.
9. Fernandez-Aviles F, San Roman JA, Garcia-Frade J, et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 2004 : 95 : 742 748.
10. Strauer BE, Brehm M, Zeus T, et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: The IACT Study. J Am Coll Cardiol 2005 : 46 : 1651 1658.
11. Hagege AA, Carrion C, Menasche P, et al. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 2003 : 361 : 491 492.
12. Menasche P, Hagege AA, Scorsin M, et al. Myoblast transplantation for heart failure. Lancet 2001 : 357 : 279 280.
13. Smith RR, Barile L, Cho HC, et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007 : 115 : 896 908.
14. Kehat I, Khimovich L, Caspi O, et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 2004 : 22 : 1282 1289. (Pubitemid 39341201)
15. Iwasaki H, Kawamoto A, Ishikawa M, et al. Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation 2006 : 113 : 1311 1325.
16. Planat-Benard V, Menard C, Andre M, et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res 2004 : 94 : 223 229.
17. Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 2004 : 364 : 141 148.
18. Lunde K, Solheim S, Aakhus S, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006 : 355 : 1199 1209.
19. Seeger FH, Tonn T, Krzossok N, Zeiher AM, Dimmeler S. Cell isolation procedures matter: A comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J 2007 : 28 : 766 772.
20. Abdel-Latif A, Bolli R, Tleyjeh IM, et al. Adult bone marrow-derived cells for cardiac repair: A systematic review and meta-analysis. Arch Intern Med 2007 : 167 : 989 997.
21. Lange R, Vogt M, Horer J, et al. Long-term results of repair of anomalous origin of the left coronary artery from the pulmonary artery. Ann Thorac Surg 2007 : 83 : 1463 1471.